Slide 1vervolg CASUS Slide 2 september 2009 -inmiddels 6 kuren R-CVP ondergaan -restadiering: PR EN NU? Slide 3 september 2009 -watch and wait -onderhoud rituximab -autologe…

Abstract:148 Frontline Therapy with the RiBVD Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final…

Slide 1 Recurrent Follicular Lymphoma With a Short First Remission: How Aggressive Should We Be? Carla Casulo, MD Wilmot Cancer Institute University of Rochester Medical…

New Agents in Management of Indolent B-Cell NHLs F B Hagemeister MD Department of Lymphoma/Myeloma M D Anderson Cancer Center Las Vegas, Nevada February 27, 2014 New Agents…

vervolg CASUS september 2009 inmiddels 6 kuren R-CVP ondergaan restadiering: PR EN NU? september 2009 watch and wait onderhoud rituximab autologe SCT onderhoud rituximab…

A Phase III Randomized Intergroup Trial (SWOG S0016) of CHOP Chemotherapy plus Rituximab vs CHOP Chemotherapy plus Iodine-131-Tositumomab for the Treatment of Newly Diagnosed…

Presentazione standard di PowerPoint Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI) Swiss Group for Clinical Cancer Research (SAKK) 1 Is there Long-Term…

New Agents in Management of Indolent B-Cell NHLs F B Hagemeister MD Department of Lymphoma/Myeloma M D Anderson Cancer Center Las Vegas, Nevada February 27, 2014 New Agents…